Moderna vaccine fully neutralizes new SARS-CoV-2 variants, study shows
Researchers in the United States have conducted a study showing that Moderna’s mRNA-1273 vaccine neutralizes all circulating variants of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) tested to date.

The novel SARS-CoV-2 virus is the agent responsible for the coronavirus disease 2019 (COVID-19) pandemic that has now caused more than 2.14 million deaths worldwide.

Clinical trial findings have previously shown that Moderna’s mRNA-1273 elicits potent neutralizing activity against SARS-CoV-2 and is highly effective at preventing symptomatic COVID-19 and severe disease.

However, concerns have arisen that the recently emerged SARS-CoV-2 variants in the United Kingdom (B.1.1.7 lineage) and the South African (B.1.351 lineage) could avoid...

for more:https://bit.ly/2VBWqCO